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Topical application of a 2.5% indomethacin (IM} solution to the sunburned skin of humans 
and guinea pigs resulted in a marked decrease in ultraviolet light (UVL)-induced erythema. 
In humans, a decrease in skin temperature and hyperalgesia to near normal levels was also 
observed. Epidermal responses to UVL injury such as keratinocyte cell death and altered 
DNA synthesis proceeded unmodified by IM. Repeated applications of IM in the 48-hr period 
following UVL exposure did not improve upon the results obtained following a single 
treatment. Guinea-pig skin provides a relevant model system for evaluating the effects of 
topical nonsteroidal anti-inflammatory agents on sunburn. 
A single topical application of indomethacin 
(IM) has been reported to relieve the redness, 
elevated skin temperature, and increased pain 
perception induced by exposure of the skin to 
ultraviolet light (UVL) or sunlight [1]. UVL-
induced cutaneous inflammation may be mediated 
by prostaglandins (PGs) which are synthesized as a 
response to trauma. IM is a potent inhibitor of PG 
biosynthesis [2] and may function to decrease 
UVL-induced inflammation by decreasing the pro-
duction of PGs. 
UVL injury produces epidermal cell death. an 
increased mitotic index, and hyperplasia, as well 
as the vascular responses of vasodilatation, altered 
permeability, and cellular exudation. This study 
evaluates the efficacy of repeated topical applica-
tions of IM along with the effects of early IM 
treatment on UVL-induced epidermal damage and 
dermal responses in human and guinea-pig skin. 
MATERIALS AND METHODS 
Ultraviolet irradiation and treatment. Informed con-
sent was obtained from 9 adult volunteers (3 female and 6 
male). Volunteers received 2 to 3 minimal erythema 
doses (MEDs) of UVL from a Westinghouse FS 20 
sunlamp on 3 areas (each approximately 4 em') of 
previously untanned buttock skin. Immediately following 
exposure to UVL 20 .,1 of solution was applied to each 
area. Site 1 was treated with 2.5% IM w/\' in the vehicle; 
site N was treated an additional 4 to 19 times with 2.5% 
IM solution at approximately 2-hr intervals throughout 
the 48-hr interim following UVL; and site V was treated 
with the vehicle alone, absolute ethanol:propylene glycol: 
dimethylacetamide 19:19:2 v/v. 
Five English short-hair female guinea pigs (weighing 
300 to 400 gm) received 4 MEDs of UVL to the right and 
left dorsal surfaces as reported previously [3]. Immedi-
ately following UVL one side was treated with 2.5% IM in 
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the vehicle and the other side was treated with vehicle 
alone. A portion of the 1M-treated side received addi-
tional applications of 2.5% IM during the 6 hr following 
UVL exposure. 
Grading system. Test sites were compared and evalu-
ated at 2, 4, 6, 8, 24, 48, 72 hr, 1, 2, and 4 weeks after 
UVL. Parameters evaluated were: intensity of erythema, 
skin temperature, pain perception, increased pigmenta-
tion (suntan), and scaling. Decreased skin redness in-
duced by topical IM was. graded on the following 0 to 3+ 
scale: 0, equivalent to site V (maximal erythema); I+, 
detectably less red than site V; 2+, definitely less red 
than site V; and 3+, equivalent in color to unirradiated 
skin. Decreased skin temperature and pain perception 
were determined as previously reported [1 ]. Suntan was 
recorded as equal to or less than site V. Scaling was 
noted when present. 
In vivo 'HTdR incorporation. At 4 and 48 hr following 
UVL, 10 I'Ci of tritiated thymidine ('HTdR, New Eng-
land Nuclear, specific activity of20 I'Ci/mmole) in 0.1 ml 
of sterile saline was injected intradermally into irradiated 
guinea-pig skin treated with 1M or vehicle and into 
comparable unirradiated skin. In 2 guinea pigs 'HTdR 
was injected into untreated UVL-irradiated skin, 1M-
treated irradiated skin, and normal skin at 1, 4, 8, 48, and 
72 hr after UVL. Punch biopsies were obtained 60 min 
later, fixed in buffered formalin, and processed for light 
microscopic autoradiography. After exposure and devel-
opment the specimens were stained with hematoxylin 
and eosin. The number of labeled basal cells was deter-
mined at 600x magnification. At least 1000 total basal 
cells were counted for each specimen. A labeling index 
was defined as the number of labeled basal cells divided 
by the total number of basal cells. 
In vitro 'HTdR incorporation. Forty-eight hours after 
UVL exposure and treatment, shallow punch biopsies 
were obtained with xylocaine anesthesia from sita 1, site 
V, and the unirradiated normal skin of 3 volunteers. The 
tissues were incubated with •HTdR as reported [4], fixed 
in buffered formalin, processed for autoradiography, and 
evaluated identically to the guinea-pig samples. 
Keratinocyte cell death. Four-millimeter punch biop-
sies from site 1, site V, and unirradiated skin were 
obtained at 24 hr after UVL exposure from 3 volunteers. 
The biopsies were fixed in buffered formalin, processed 
for light microscopy, and stained with hematoxylin and 
rosin. The number of abnormally staining cells with 
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pyknotic nuclei-the sunburn cells-was determined in 
10 microscopic fields at 600 x magnification. At least 60 
fields were counted per specimen. 
RESULTS 
In this study IM treatment delayed the appear-
ance of redness in all subjects until 2 to 4 hr after 
the vehicle- treated site became red. In all volun-
teers and guinea pigs additional applications of IM 
provided no further improvement in efficacy over 
that observed following a single inunction. The 
data for one and many treatments of IM were 
pooled together and are referred to collectively as 
1M-treated skin. 
In Table I a comparison of the 1M-treated skin 
with the vehicle-treated site shows that through 24 
hr after treatment all subjects experienced de-
creased redness, with 8 of the 9 showing a 2+ 
decrease in erythema. Cooler skin temperature 
{approaching normal) was noted in all the drug-
treated sites. Five of the 9 subjects experienced a 
lessening of the UVL-induced hyperalgesia to near 
normal pain perception in 1M-treated skin while 4 
subjects received insufficient UVL and ex-
perienced no hyperalgesia in any of the irradiated 
sites. 
TABLE I. Response of human sunburned skin to topical 
indomethacin" 
Red- Temper-




decrease 9" 9 5I 8 0 
Subjects 
showing 
no effect l 9 
• Nine subjects were studied. 
• Evaluated at 24 hr after UVL and treatment. 
,. Evaluated l month after UVL and treatment. 
"Evaluated throughout the l month of follow-up. 
'Eight of the 9 subjects had a 2+ decrease in redness. l 
had a 1 • response. 
' Four subjects had normal pain perception in all 
UVL-exposed areas. 
By one week after UVL exposure all subjects 
showed increased pigmentation in every UVL-
exposed area, with 8 of the 9 exhibiting a slightly 
darker degree of pigmentation in the vehicle-
treated site than in the 1M-treated areas. This ob-
servation persisted for at least one month at 
which time no trace of erythema was evident to 
interfere with the evaluation. The decrease of 
UVL-stimulated melanogenesis in 1M-treated skin 
was slight but seemed to parallel the intensity and 
duration of the subject's response to IM treatment. 
The only subject who responded with a 1 + decrease 
in redness experienced no detectable decrease in 
UVL-induced pigmentation in the 1M-treated 
skin. 
All skin sites exposed to UVL in all subjects 
showed wrinkling and scaling at some time in the 1-
month follow-up period. It was not possible to 
distinguish differences among the 3 irradiated 
sites. 
Mter IM treatment all of the subjects in Table II 
exhibited marked decreases in the dermal symp-
toms of sunburn, i.e., redness, elevated tempera-
ture, and hyperalgesia. In spite of this dramatic 
dermal response there was little significant effect 
on the UVL-induced epidermal damage or kerati-
nocyte death as evidenced by the similar number 
of sunburn cells present in both the vehicle-treated 
and 1M-treated skin_ The number of sunburn cells 
was always somewhat less in the drug-treated skin. 
Even if this trend were borne out in a larger number 
of subjects, the degree of the amelioration would 
not be very remarkable. Histologically, 24 hr after 
UVL, the 1M-treated and vehicle-treated sites 
appeared similar, showing capillary dilatation, 
perivascular infiltrate, and intracellular epidermal 
edema. The labeling index included in Table II 
shows nearly identical elevation at 48 hr after UVL 
exposure in both 1M-treated and vehicle-treated 
skin. 
Preliminary results in 2 guinea pigs showed no 
differences between the labeling index of 1M-
treated and nontreated UVL-exposed skin. The 
labeling index was lowest at 4 hr after UVL and 
highest at 48 hr. At 4 hr following UVL irradiation 
the decrease in in vivo incorporation of 'HTdR into 
guinea-pig skin was unaffected by treatment with 
TABLE II. Epidermal effects of indomethacin on sunburned human skin 
Keratinocyte cell death ~HTdR incorporation 
Number of sunburn ceHsa Labeling lndex"' 48 hr after UVL and treatment 
/10 microscope fi-elds 
UL V + vehicle UVL+ indo· Subject Control UVL + vehicle VVL+indo· Subject 
methacin metha.cin 
JP 19.6 ± 3.0 18.0 ± 3.7 JP .073 ± .021 .328 ± .051 .291 ± .052 
BM 39.3 ± 5.6 35.0 ± 4.2 BM .067 ± .010 .237 ± .050 .258 ± .050 
FS 40.0 ± 6.2 32.8 ± 6.9 JW .049 ± .0072 - .272"' .033 
Mean 33.0 ± 5.1 28.6 ± 6.0 Mean .063 ± .018 .283 ± .060 .274 ± .053 
• Mean value ± 1 standard deviation. See text for details. 
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TABLE ill. In vivo •HTdR incorporation into sunburned guinea-pig skin 
Labeling index at 4 hr after UVL Labeling index at 48 hr after UVL 
Subject UVL +indo· UVL +indo· Control UVL + vehicle Control UVL + vehicle 
methacin methacin 
#1 .038 .036 .036 
112 .060 .013 .0085 
i/3 .030 .0072 .0038 
#4 .054 .019 .014 
115 ,070 .00 .003 
Mean .050 .015 .013 
topical IM (Tab. ill) even though the treated skin 
appeared grossly normal and the vehicle-treated 
skin was bright red at that time. A decrease in 
erythema at the 1M-treated site remained obvious 
in all animals for at least 24 br after treatment. By 
48 br after UVL exposure, Table III shows the 
increase in labeling index was identical for both 
drug-treated and vehicle-treated UVL-exposed 
guinea-pig skin. Scaling became evident by 1 week 
after UVL exposure in both 1M-treated and vehi-
cle-treated skin. 
DISCUSSION 
.038 .308 .297 
.060 .297 
-
.040 .412 .350 
.027 .292 .297 
.076 .362 .382 
.048 .334 .332 
epidermal damage caused by the direct action of 
UVL would still remain while the subsequent 
dermal responses induced by the mediator would 
be decreased. IM is a known inhibitor of PGE 
biosynthesis [2] and it may be acting by decreasing 
PGE levels in the tissue. If this is true then why 
doesn't IM totally eliminate the dermal symptoms 
of sunburn? Perhaps PGE plays an important role 
in the early phase of sunburn (0-24 hr) where IM is 
most effective, but other mediators play an impor· 
tant role in the later phases. Alternative modes of 
action for IM, e.g., a direct effect on the vascula-
ture or inhibition or antagonism of other mediators 
of inflammation, have not been eliminated and 
could also explain our data. Further work is 
required to define this mechanism. 
IM is a potent anti-inflammatory agent and it 
has potentially toxic side effects [9). Since the 
percutaneous absorption and cutaneous toxicity of 
this drug are not currently known, the use of 
topical IM should proceed with caution. It is 
noteworthy that repeated applications of IM are 
not necessary to achieve a marked decrease in 
dermal reactions to UVL injury since a single 
application should minimize exposure to the drug 
and thus also minimize the risk of absorption. 
Knowledge of the amount of IM which penetrates 
into the skin should allow an evaluation of the 
benefit to risk ratio for this treatment of sunburn. 
Based on the data presented here, topical indo-
methacin will decrease the dermal symptoms of 
sunburn while leaving the epidermal damage-as 
reflected by alterations in DNA synthesis and the 
number of sunburn cells-relatively unchanged. 
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We have confirmed our earlier findings that 
topical application of an inhibitor of the PG 
synthetase system, IM, to sunburned skin can 
decrease the symptoms which result from exposing 
the skin to UVL [1). While the dermal components 
of UVL-induced inflammation are reduced by IM 
treatment, there is little or no effect seen on the 
UVL-induced epidermal damage in human and 
guinea-pig skin. This remarkably similar response 
of sunburned guinea-pig and human skin to topical 
IM extends our previous observations [3] that 
UVL-inflamed human and guinea-pig skin react 
identically to intradermal injections of nonsteroi-
dal anti-inflammatory drugs. Alteration in DNA 
synthesis and the sloughing of necrotic epidermis 
go unchecked by IM treatment while in humans a 
minor decrease is noted in UVL-induced melano-
genesis and in the number of degenerating sunburn 
cells. Our data are consistent with a current theory 
which purports to explain the delayed phase of 
erythema development induced by 290 to 320 nm 
light by invoking the concept of one or more 
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then diffuse into the dermis to cause vasodilatation 
resulting in erythema and elevated skin tempera-
ture. PGE is thought to be a likely candidate for 
such a mediator because: (1) PGE can cause 
sustained vasodilatation after intradermal injec-
tion [5, 6 ]. (2) PGE can be synthesized by enzymes 
in the mammalian epidermis [7). (3) PGE-like 
compounds are present in elevated amounts in 
dermal perfusates of traumatized skin [8]. (4) 
Inhibitors of PGE biosynthesis can inhibit the 
delayed phase of erythema [3]. If it were possible to 
inhibit the production of such a mediator, then the 6. Bergstrom S, Carlson LA, Ekelund LG, Oro L: Cardi-
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